Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score32

United States Fiscal year ends December CIK 0001607678 Results filed 28 Oct 2026

Add to watchlist

What the insiders did Net selling

By person

14 insiders · 125 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Brian Lian

President & CEO

—

$74.66M (36) scheduled

−$74.66M

2,572,441

2.21%

$86.09M

+72.0%

Marianna Mancini

Chief Operating Officer

—

$32.19M (19) scheduled

−$32.19M

422,760

0.3624%

$14.15M

+260.0%

Greg Zante

Chief Financial Officer

—

$26.05M (30) scheduled

−$26.05M

212,204

0.1819%

$7.10M

+335.2%

Ligand Pharmaceuticals Inc entity

10% owner

—

$6.36M (3)

−$6.36M

5,819,383

4.99%

$194.75M

−6.8%

J Matthew Singleton

Director

$93.26K (1)

$4.58M (11) scheduled

−$4.48M

12,650

0.0108%

$423.33K

—

Charles A Rowland Jr

Director

$154.80K (1)

$3.13M (2) scheduled

−$2.98M

33,150

0.0284%

$1.11M

—

Sarah Kathryn Rouan

Director

$29.94K (1)

$2.28M (3) scheduled

−$2.25M

4,390

0.0038%

$146.91K

—

Lawson Macartney

Director

$250.33K (1)

$1.29M (4) scheduled

−$1.04M

51,115

0.0438%

$1.71M

—

Matthew W Foehr

Director

$240.67K (3)

$657.24K (2) scheduled

−$416.57K

135,186

0.1159%

$4.52M

+415.0%

Michael Morneau

VP, Finance and Administration

—

$199.35K (1)

−$199.35K

116,062

0.0995%

$3.88M

−5.4%

Neil William Aubuchon

Chief Commercial Officer

$149.91K (1)

—

+$149.91K

4,475

0.0038%

$149.76K

—

Stephen W Webster

Director

$41.71K (1)

—

+$41.71K

8,000

0.0069%

$267.72K

—

Hiroko Masamune

Chief Development Officer

—

—

—

141,063

0.1209%

$4.72M

+36.4%

Dorothy Elizabeth Kelly-Gemmell

Director

—

—

—

6,333

0.0054%

$211.94K

—